Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis
Article first published online: 19 OCT 2009
© 2009 The Authors. Journal compilation © 2009 Paediatrics and Child Health Division (Royal Australasian College of Physicians)
Journal of Paediatrics and Child Health
Volume 45, Issue 11, pages 681–683, November 2009
How to Cite
Rosenbaum, J., Alex, G. and Clarnette, T. (2009), Ursodeoxycholic acid's role in avoiding diversionary surgery in idiopathic fibrosing pancreatitis. Journal of Paediatrics and Child Health, 45: 681–683. doi: 10.1111/j.1440-1754.2009.01595.x
- Issue published online: 29 OCT 2009
- Article first published online: 19 OCT 2009
- Accepted for publication 20 January 2009.
- ursodeoxycholic acid
Obstructive jaundice in childhood is rare but a cause of great concern and warrants aggressive investigation into its aetiology. Idiopathic fibrosing pancreatitis (IFP) is a rare cause of this phenomenon and is presently a diagnosis of exclusion with lymphoma a main differential diagnosis. IFP appears to be a self limiting occurrence and as a result the previous gold standard of therapy of surgical diversion may ultimately be unnecessary. We describe ursodeoxycholic acid as a useful adjunct to treatment allowing more time for clinicians to evaluate the nature of the underlying disease process without hastily moving towards invasive surgery until clearly indicated.